Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,781
datasets available to search
ShareScore release 0.9.0
Dataset results
1,781 results for “new type”
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT02093221. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes
ClinicalTrials.gov study NCT03268005. IPD Sharing: YES. Countries: 18. Publications: 2.
A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)
ClinicalTrials.gov study NCT05823948. IPD Sharing: YES. Countries: 1. Publications: 1.
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before
ClinicalTrials.gov study NCT04460885. IPD Sharing: YES. Countries: 13. Publications: 8.
The Effect of Gluten-free Diet on New Onset Type 1 Diabetes (T1D)
ClinicalTrials.gov study NCT02867436. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type
ClinicalTrials.gov study NCT04880850. IPD Sharing: YES. Countries: 9. Publications: 6.
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
ClinicalTrials.gov study NCT02119819. IPD Sharing: YES. Countries: 6. Publications: 1.
Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2
ClinicalTrials.gov study NCT01047540. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes
ClinicalTrials.gov study NCT01790438. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes
ClinicalTrials.gov study NCT04233034. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes
ClinicalTrials.gov study NCT02218619. IPD Sharing: YES. Countries: 1. Publications: 1.
Rituximab in New Onset Type 1 Diabetes
ClinicalTrials.gov study NCT00279305. IPD Sharing: YES. Countries: 4. Publications: 11.
A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)
ClinicalTrials.gov study NCT04848480. IPD Sharing: YES. Countries: 12. Publications: 4.
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly
ClinicalTrials.gov study NCT05259033. IPD Sharing: YES. Countries: 14. Publications: 1.
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
ClinicalTrials.gov study NCT01676220. IPD Sharing: Not stated. Countries: 16. Publications: 4.
A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Dia
ClinicalTrials.gov study NCT06340854. IPD Sharing: YES. Countries: 9. Publications: 0.
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly
ClinicalTrials.gov study NCT05352815. IPD Sharing: YES. Countries: 22. Publications: 1.
Tocilizumab (TCZ) in New-onset Type 1 Diabetes
ClinicalTrials.gov study NCT02293837. IPD Sharing: YES. Countries: 2. Publications: 2.
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin
ClinicalTrials.gov study NCT04770532. IPD Sharing: YES. Countries: 9. Publications: 6.
Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
ClinicalTrials.gov study NCT03191396. IPD Sharing: YES. Countries: 12. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.